These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17191033)

  • 1. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
    Rysavá R; Kalousová M; Zima T; Dostál C; Merta M; Tesar V
    Kidney Blood Press Res; 2007; 30(1):1-7. PubMed ID: 17191033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
    Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.
    Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
    Clin Chim Acta; 2007 Apr; 379(1-2):87-94. PubMed ID: 17292872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation.
    Kalousová M; Bartosová K; Zima T; Skibová J; Teplan V; Viklický O
    Kidney Blood Press Res; 2007; 30(1):31-7. PubMed ID: 17237617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.
    Witko-Sarsat V; Friedlander M; Nguyen Khoa T; Capeillère-Blandin C; Nguyen AT; Canteloup S; Dayer JM; Jungers P; Drüeke T; Descamps-Latscha B
    J Immunol; 1998 Sep; 161(5):2524-32. PubMed ID: 9725252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
    Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M
    Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
    Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble receptor for advanced glycation end products in patients with decreased renal function.
    Kalousová M; Hodková M; Kazderová M; Fialová J; Tesar V; Dusilová-Sulková S; Zima T
    Am J Kidney Dis; 2006 Mar; 47(3):406-11. PubMed ID: 16490618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
    Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP).
    Chiu-Braga YY; Hayashi SY; Schafranski M; Messias-Reason IJ
    Int J Cardiol; 2006 May; 109(2):275-6. PubMed ID: 15946754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respective role of uraemic toxins and myeloperoxidase in the uraemic state.
    Capeillère-Blandin C; Gausson V; Nguyen AT; Descamps-Latscha B; Drüeke T; Witko-Sarsat V
    Nephrol Dial Transplant; 2006 Jun; 21(6):1555-63. PubMed ID: 16476719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
    Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
    J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
    Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
    Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of oxidation-reduction level in patients with rheumatoid arthritis].
    Cai WC; Wang H; Li RQ; Gao L
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):749-50. PubMed ID: 15958331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory findings and serum levels of amyloid A and soluble interleukin-2 receptors in patients with renal amyloidosis].
    Rysavá R; Merta M; Tesar V; Zabka J; Spicka I; Stejskalová A; Vernerová Z
    Cas Lek Cesk; 1998 Feb; 137(4):107-9. PubMed ID: 9531732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
    Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.